Cizzle Biotechnology Holdings Plc (LON:CIZ)
London · Delayed Price · Currency is GBP · Price in GBX 1.300
-0.200 (-13.33%)
Sep 4, 2026, 4:29 PM GMT
LON:CIZ Market Cap
LON:CIZ has a market cap or net worth of 5.95 million as of September 4, 2026. Its market cap has increased by 7.21% in one year.
Market Cap
5.95M
Enterprise Value
5.83M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.30
ChartMarket Cap Chart
Since May 14, 2021, LON:CIZ's market cap has decreased from 23.76M to 5.95M, a decrease of -74.96%. That is a compound annual growth rate of -22.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 6.37M | 3.75% |
| Dec 31, 2025 | 6.14M | - |
| Dec 31, 2024 | 6.14M | -13.40% |
| Dec 29, 2023 | 7.09M | 40.94% |
| Dec 30, 2022 | 5.03M | -33.79% |
| Dec 31, 2021 | 7.60M | -68.00% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IXICO | 16.35M |
| Fusion Antibodies | 14.71M |
| Genflow Biosciences | 12.18M |
| Aptamer Group | 12.09M |
| Solvonis Therapeutics | 8.17M |
| CRISM Therapeutics | 6.10M |
| OptiBiotix Health | 5.94M |
| Thalia Therapeutics | 5.20M |